Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Lothgren · SciRah

Researcher profile · Semantic Scholar

M. Lothgren

Share profile

M. Lothgren — researcher profile on SciRah

h-index: 25
Works: 119
Citations: 3,375

Most-cited papers

Likelihood-Based Cointegration Tests in Heterogeneous Panels
Rolf Larsson, Johan Lyhagen, M. Lothgren
2001607 citations Open access
Semantic Scholar
Definition, interpretation and calculation of cost-effectiveness acceptability curves.
M. Lothgren, N. Zethraeus
2000Health Economics312 citations
Semantic Scholar
On stationarity and cointegration of international health expenditure and GDP.
U. Gerdtham, M. Lothgren
2000Journal of Health Economics290 citations
Semantic Scholar
On the power and interpretation of panel unit root tests
Sune Karlsson, M. Lothgren
1999278 citations Open access
Semantic Scholar
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
S. Quilici, J. Chancellor, M. Lothgren, D. Simon +4 more
2009BMC Neurology227 citations Open access
Semantic Scholar
Productivity and customer satisfaction in Swedish pharmacies: A DEA network model
M. Lothgren, M. Tambour
1999European Journal of Operational Research146 citations
Semantic Scholar
Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies
N. Zethraeus, M. Johannesson, B. Jönsson, M. Lothgren +1 more
2003PharmacoEconomics (Auckland)129 citations
Semantic Scholar
Do we fully understand the economic value of vaccines?
M. Drummond, C. Chevat, M. Lothgren
2007Vaccine93 citations
Semantic Scholar
Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
S. Gandra, G. Villa, G. Fonarow, M. Lothgren +3 more
2016Clinical Cardiology90 citations Open access
Semantic Scholar
New panel results on cointegration of international health expenditure and GDP
U. Gerdtham, M. Lothgren
200287 citations
Semantic Scholar
Testing scale efficiency in DEA models: a bootstrapping approach
M. Lothgren, M. Tambour
199960 citations
Semantic Scholar
Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.
G. Villa, M. Lothgren, L. Kutikova, P. Lindgren +6 more
2016Clinical Therapeutics53 citations Open access
Semantic Scholar
Acute and chronic impact of cardiovascular events on health state utilities
L. Matza, K. Stewart, S. Gandra, P. Delio +5 more
2015BMC Health Services Research44 citations Open access
Semantic Scholar
The interactions between quality, productivity and economic performance: The case of Swedish pharmacies
A. Westlund, M. Lothgren
200142 citations
Semantic Scholar
The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden
M. Willis, M. Svensson, M. Lothgren, B. Eriksson +2 more
2010European Journal of Health Economics41 citations
Semantic Scholar
The cost‐effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective
J. Hornberger, J. Rickert, R. Dhawan, J. Liwing +2 more
2010European Journal of Haematology41 citations
Semantic Scholar
Specification and estimation of stochastic multiple-output production and technical inefficiency
M. Lothgren
200040 citations
Semantic Scholar
Economic evidence in affective disorders: a review
M. Lothgren
2004European Journal of Health Economics32 citations
Semantic Scholar
Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
O. Ghatnekar, T. Alvegård, N. Conradi, S. Lenhoff +3 more
2008Clinical Therapeutics27 citations
Semantic Scholar
Economic evidence in anxiety disorders: a review
M. Lothgren
2004European Journal of Health Economics25 citations
Semantic Scholar
Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Protease Inhibitor-Experienced, HIV-1-Infected Adults in Belgium, Italy, Sweden and the UK
K. Moeremans, L. Annemans, M. Lothgren, G. Allegri +4 more
2012PharmacoEconomics (Auckland)23 citations
Semantic Scholar
Health system effects on cost efficiency in the OECD countries
U. Gerdtham, M. Lothgren
200123 citations
Semantic Scholar
Cost effectiveness of long-acting risperidone in Sweden
M. Hensen, B. Heeg, M. Lothgren, B. van Hout
2010Applied Health Economics and Health Policy19 citations
Semantic Scholar
A Pharmacoeconomic analysis of compliance gains on antipsychotic medications
J. Damen, P. Thuresson, B. Heeg, M. Lothgren
2008Applied Health Economics and Health Policy19 citations
Semantic Scholar
Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland
M. Lothgren, E. Ribnicsek, L. Schmidt, W. Habacher +5 more
2013European Journal of Hospital Pharmacy: Science and Practice18 citations Open access
Semantic Scholar
A cost-effectiveness analysis of escitalopram as first line treatment of depression in Sweden
M. Lothgren, M. Hemels, C. François, B. Jönsson
200418 citations
Semantic Scholar
Pharmaceutical industry's perspective on health technology assessment
M. Lothgren, M. Ratcliffe
2004International Journal of Technology Assessment in Health Care18 citations
Semantic Scholar
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
C. Asseburg, M. Willis, M. Lothgren, N. Seppälä +2 more
2012Schizophrenia Research and Treatment17 citations Open access
Semantic Scholar
Economic evidence in psychotic disorders: a review
M. Lothgren
2004European Journal of Health Economics17 citations
Semantic Scholar
Bootstrapping the Malmquist Productivity Index: A Simulation Study
M. Lothgren
199917 citations
Semantic Scholar
Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden
O. Ghatnekar, C. Hjortsberg, M. Gisslén, Stefan Lindbäck +1 more
2012PharmacoEconomics (Auckland)15 citations
Semantic Scholar
Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic
J. Cristino, J. Finek, P. Jandová, M. Kolek +5 more
2017Journal of Medical Economics13 citations Open access
Semantic Scholar
PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the Netherlands
M. Lothgren, A. Bracco, B. Lucius, K. Northridge +4 more
201112 citations Open access
Semantic Scholar
Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
Gunilla Journath, K. Hambraeus, E. Hagström, B. Pettersson +1 more
2017BMC Cardiovascular Disorders9 citations Open access
Semantic Scholar
On the consistency of the DEA-based average efficiency bootstrap
M. Lothgren
20008 citations
Semantic Scholar
Length of hospital stay and associated costs for olanzapine vs. haloperidol in the treatment of schizophrenia relapse in Germany
A. Spannheimer, U. Reitberger, J. Clouth, M. Lothgren
2003European Journal of Health Economics6 citations
Semantic Scholar
On the equivalence of the net benefit and the Fieller's methods for statistical inference in cost-effectiveness analysis
N. Zethraeus, M. Lothgren
20006 citations
Semantic Scholar
Specification and estimation of stochastic multiple-output production and technical inefficiency
M. Lothgren
20006 citations
Semantic Scholar
Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies.
L. Steuten, M. Lothgren, Andrew Bruce, M. Campioni +1 more
2024Value in Health5 citations Open access
Semantic Scholar
Computationally efficient double bootstrap variance estimation
Sune Karlsson, M. Lothgren
20005 citations
Semantic Scholar
Why We Need a New Outcomes-Based Value Attribution Framework for Combination Regimens in Oncology.
A. Towse, M. Lothgren, L. Steuten, Andrew Bruce
2022Value in Health4 citations Open access
Semantic Scholar
PCN103 - PREDICTED TREATMENT COSTS AND SAVINGS PER PATIENT OF KANJINTI® (TRASTUZUMAB BIOSIMILAR) VS. SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) HERCEPTIN® AND OTHER TRASTUZUMAB BIOSIMILARS IN ITALY
I. Agirrezabal, I. Gaikwad, L. Cirillo, M. Lothgren
2018Value in Health4 citations Open access
Semantic Scholar
Abstract 18114: Differences Between Observed and Predicted Cardiovascular Event Rates Using the Framingham and REACH Equations: The Case of High-intensity Statin Users in the United Kingdom
Ben Taylor, M. Lothgren, G. Villa, P. Lindgren +2 more
20154 citations
Semantic Scholar
THE IMPACT OF SOCIOECONOMIC FACTORS ON PUBLIC HEALTH CARE EXPENDITURE IN ASEAN COUNTRIES
Nee-Au-Yong Hui, Au H. N. Yong, Yit-Jen Chong, Qi-Xiong Ng +185 more
2021Journal of Environmental Science and Sustainable Development3 citations Open access
Semantic Scholar
Avoiding Overestimation In Annualization of Event Risk from Risk Functions for use in Economic Modeling.
M. Lothgren, Mark D. Danese, B. Taylor, Guillermo Villa
2015Value in Health3 citations Open access
Semantic Scholar
Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective.
A. Hauber, J. Fleischmann, M. Lothgren, Michele Wilson +3 more
2011Journal of Opioid Management3 citations
Semantic Scholar
PMH3 A COST-EFFECTIVENESS COMPARISON OF OLANZAPINE AND RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA IN ITALY
S. Beard, M. Lothgren, L. Giudi, F. Ramacciotti +2 more
20023 citations Open access
Semantic Scholar
On the interpretation of cost-effectiveness acceptability curves
M. Lothgren, N. Zethraeus
20003 citations
Semantic Scholar
Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: a modeling analysis based on the CheckMate 9ER study
D. Cella, M. Derosa, L. Floden, R. Giles +8 more
2025ESMO Open2 citations
Semantic Scholar
LBP-027 Elafibranor improves fatigue versus placebo in patients with primary biliary cholangitis, with limited correlation with pruritus: analyses from the phase III ELATIVE® trial
David E. Jones, Marco Carbone, Andreas E. Kremer, C. Levy +9 more
2025Journal of Hepatology2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Zethraeus×4
Invite
N. Zethraeus — researcher profile on SciRah
B. van Hout×4
Invite
B. van Hout — researcher profile on SciRah
U. Gerdtham×3
Invite
U. Gerdtham — researcher profile on SciRah
M. Tambour×3
Invite
M. Tambour — researcher profile on SciRah

×3

Invite

S. Gandra — researcher profile on SciRah

Invite

G. Villa — researcher profile on SciRah

Invite

P. Lindgren — researcher profile on SciRah

Invite

U. Persson — researcher profile on SciRah

Sune Karlsson×2

Invite

Sune Karlsson — researcher profile on SciRah

Invite

G. Fonarow — researcher profile on SciRah

Invite

M. Willis — researcher profile on SciRah

O. Ghatnekar×2

Invite

O. Ghatnekar — researcher profile on SciRah